Clinical Trial Update: A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dosing regimens of intravitreal ranibizumab for macular edema following retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Macular Edema | Phase 4 | Status: COMPLETED | Results posted: 2014-04-23